Veru amends forbearance with Onconetix; extends note maturities, adjusts payment terms

VERU INC.

Veru entered amended forbearance agreement with Onconetix for two promissory notes totaling $10M principal.
Forbearance period for April 2024 note extended to March 31, 2025; September 2024 note maturity extended to June 30, 2025.
Interest accrues at 10% per annum on unpaid balances from specified dates.
Payment terms increased: 25% of monthly cash receipts and 20% of net financing proceeds.
If both notes fully repaid in cash by Dec 31, 2024, September 2024 note principal reduced from $5M to $3.5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.